Download answers_ch07

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Peptide synthesis wikipedia , lookup

Expanded genetic code wikipedia , lookup

Neurotransmitter wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

Deoxyribozyme wikipedia , lookup

Ligand binding assay wikipedia , lookup

Drug design wikipedia , lookup

Biochemistry wikipedia , lookup

Bottromycin wikipedia , lookup

NMDA receptor wikipedia , lookup

Signal transduction wikipedia , lookup

Index of biochemistry articles wikipedia , lookup

G protein–coupled receptor wikipedia , lookup

Nucleic acid analogue wikipedia , lookup

Transcript
Patrick: An Introduction to Medicinal Chemistry 3/e
Chapter 7: Nucleic acids as drug targets
Answers
1) The proposed reaction would occur as follows.
NH2
N
Puromycin
N
HO
NH2
N
N
N
N
O
O
O
P
N
O
N
O
OMeO
O
NH
OH
O
O
OH
tRNA
Aminoacyl-tRNA
NH
Peptide
R
NH2
O
NH2
N
N
NH2
N
N
HO
N
O
N
O
N
P
O
N
O
O-
O
O
O
OH
R
NH
tRNA
NH2
OH
MeO
O
NH
Peptide
O
However, this reaction is very unlikely to occur. The reaction involves nucleophilic
substitution of an amide rather than an ester. Amides are less reactive to
nucleophilic substitution. Moreover, there is no guarantee that the puromycinpeptide complex would emain bound to the ribosome since it lacks the t-RNA
moiety and the base pairing to the mRNA present.
2) Proflavine contains a planar, heteroaromatic, tricyclic ring which could slip
between the base pairs of DNA and interact with the base pairs above and below
it though van der Waals interactions. The amino groups are likely to be ionised at
OXFORD
© Oxford University Press, 2006. All rights reserved.
Higher Education
Patrick: An Introduction to Medicinal Chemistry 3/e
Chapter 7: Nucleic acids as drug targets
physiological pH and could form ionic bonds with the charged phosphate groups
of the DNA sugar phosphate backbone (see also section 16.8.2).
The drug is unlikely to show any selectivity between the DNA of bacteria and the
DNA of human cells. Therefore, it cannot be used systemically.
3) The nucleosides which are mimiced are deoxyguanosine, deoxycytidine and
deoxythymidine respectively (see also section 17.6.1).
O
N
N
O
N
O
O
O
H
H
H
H
H
H
H
H
H
H
H
H
OH H
OH H
OH H
Deoxycytidine
Deoxyguanosine
N
HO
HO
HO
CH3
HN
N
N
N
H2N
O
NH2
O
Deoxythymidine
4) It is possible to identify five CN fragments within the skeleton of adenine as
shown below.
NH2
N
N
N
N
H
5) The table in appendix 2 can be used to answer this question. A change in Z is
least likely to result in a change of amino acid. For example, CUU, CUC, CUA
and CUG all code for leucine.
6)
AGU to ACU
This changes serine to threonine. Both these molecules contain an alcohol
functional group in their side chain and so it is possible that the receptor would
still be functional. The increased bulk of threonine might have an effect on the
range of ligands which could bind.
AGU to GGU
Serine is changed to glycine. Glycine has no side chain and so an important
binding group is lost. The receptor is unlikely to be functional.
OXFORD
© Oxford University Press, 2006. All rights reserved.
Higher Education
Patrick: An Introduction to Medicinal Chemistry 3/e
Chapter 7: Nucleic acids as drug targets
AGU to AGC
Serine is retained. The identical receptor will result.
GAAto GAU
Glutamate is changed to aspartate. Both residues contain a carboxylate group
that can interact through ionic interactions. It is likely that the mutated receptor
will still be functional. However, the relative activity of different ligands may alter
since the aspartate residue is shorter than the glutamate residue.
GAA to AAA
Glutamate is changed to lysine. If lysine is ionised, it will have a positive charge
rather than a negative charge. The same binding interactions are not possible
and so the receptor is unlikely to be functional with existing ligands.
However, it is conceivable that the receptor might be active with ligands bearing a
carboxylate group since this would permit an ionic interaction to take place.
GAA to GUA
Glutamate is changed to valine. Valine has an alkyl side chain. An important ionic
binding interaction is lost and the receptor is likely to be non functional.
UUU to UUC
Phenylalanine is retained. The receptor is unaffected.
UUU to UAU
Phenylalanine is changed to tyrosine. Tyrosine is very similar to phenylalanine
and contains an aromatic ring. Therefore, there is a good chance that the
receptor will still be functional.
UUU to AUU
Phenylalanine is changed to isoleucine. Isoleucine contains an alkyl side chain
and no aromatic ring. Both groups can interact with hydrophobic groups on
ligands through van der Waals interactions, but it is likely that the mutation will
have an effect on receptor activity due to the different sizes and shapes of the
residues. The aromatic ring of phenylalanine is planar, whereas the alkyl side
chain of isoleucine is branched and bulky. The receptor may still be functional,
but it it is likely the relative activity of ligands would be significantly affected.
OXFORD
© Oxford University Press, 2006. All rights reserved.
Higher Education